다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Lucid Diagnostics Inc (LUCD)
Lucid Diagnostics Inc (LUCD) 뉴스

LUCD

Lucid Diagnostics (LUCD)

Lucid Diagnostics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LUCD

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/14	19:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/05/14	09:43	PR Newswire (US)	PAVmed Provides Business Update and First Quarter 2024 Financial Results	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/05/13	21:21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/05/13	21:00	PR Newswire (US)	Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/05/10	10:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/05/10	10:57	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/05/09	20:49	PR Newswire (US)	Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/05/09	05:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/05/09	05:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/05/07	20:50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/05/07	20:39	PR Newswire (US)	Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/05/02	21:35	PR Newswire (US)	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/05/02	20:49	PR Newswire (US)	Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/04/29	21:47	PR Newswire (US)	Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/04/08	21:30	PR Newswire (US)	Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/03/27	08:32	PR Newswire (US)	PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/03/26	06:30	PR Newswire (US)	Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/03/21	22:30	PR Newswire (US)	Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/03/20	21:30	PR Newswire (US)	Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/03/12	21:30	PR Newswire (US)	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/02/24	06:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/02/17	07:00	PR Newswire (US)	Lucid Diagnostics Provides Update Regarding World Trade Center Health Program	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/02/15	21:45	PR Newswire (US)	Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/02/08	21:45	PR Newswire (US)	Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/02/07	07:24	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/02/07	07:20	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/01/31	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUCD	Lucid Diagnostics Inc
2023/12/12	22:30	PR Newswire (US)	Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies	NASDAQ:LUCD	Lucid Diagnostics Inc
2023/12/11	23:00	PR Newswire (US)	PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders	NASDAQ:LUCD	Lucid Diagnostics Inc
2023/12/05	06:20	PR Newswire (US)	PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split	NASDAQ:LUCD	Lucid Diagnostics Inc

검색 관련기사 보기:NASDAQ:LUCD

1 2 3 4 5 6 7 다음 >>

US Dollar vs CLP

Itiquira Acquisition

Brii Bioscience (PK)

First Trust SNetwork Fut...

Vontobel Financial Produ...

Ishares MSCI Europe ESG ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관